Intrinsiqs

Is Structure Therapeutics Inc. overvalued?

Structure Therapeutics Inc. (GPCR) — key valuation metrics and fundamentals.

No verdict
Price
$53.29
Fair value
Current P/E
Normal P/E
Market cap
$3.07B
Dividend yield
0.0%
Return on equity
-16.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GPCR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.